INOGEN, INC.: 10-Q filed 2024-11-08
What INOGEN, INC. reported in its quarterly report filed 2024-11-08 (fiscal Q3 2024): 51 published measures, 140 facts as tagged in accession 0000950170-24-124115.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2024-11-08
- Fiscal period
- fiscal Q3 2024
- Accession
- 0000950170-24-124115 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INOGEN, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 306,172,000 | USD | |
| At 2023-12-31 | 326,194,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 120,768,000 | USD | |
| At 2023-12-31 | 121,382,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 185,404,000 | USD | |
| At 2024-06-30 | 187,595,000 | USD | |
| At 2023-12-31 | 204,812,000 | USD | |
| At 2023-09-30 | 230,630,000 | USD | |
| At 2023-06-30 | 274,779,000 | USD | |
| At 2022-12-31 | 297,406,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 105,690,000 | USD | |
| At 2023-12-31 | 125,492,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | -5,963,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -26,131,000 | USD | 274 |
| 2023-07-01 to 2023-09-30 | -45,719,000 | USD | 92 |
| 2023-01-01 to 2023-09-30 | -75,894,000 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | 8,932,000 | USD | 274 |
| 2023-01-01 to 2023-09-30 | -86,000 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | 3,031,000 | USD | 274 |
| 2023-01-01 to 2023-09-30 | 3,824,000 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 88,834,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 255,624,000 | USD | 274 |
| 2023-07-01 to 2023-09-30 | 83,967,000 | USD | 92 |
| 2023-01-01 to 2023-09-30 | 239,764,000 | USD | 273 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 74,929,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 212,449,000 | USD | 274 |
| 2023-07-01 to 2023-09-30 | 67,973,000 | USD | 92 |
| 2023-01-01 to 2023-09-30 | 192,203,000 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | 525,000 | USD | 274 |
| 2023-01-01 to 2023-09-30 | 974,000 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | -25,515,000 | USD | 274 |
| 2023-01-01 to 2023-09-30 | -63,443,000 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | -143,080,000 | USD | |
| At 2023-12-31 | -116,949,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 23,751,168 | shares | 92 |
| 2024-01-01 to 2024-09-30 | 23,589,836 | shares | 274 |
| 2023-07-01 to 2023-09-30 | 23,231,217 | shares | 92 |
| 2023-01-01 to 2023-09-30 | 23,129,795 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 23,751,168 | shares | 92 |
| 2024-01-01 to 2024-09-30 | 23,589,836 | shares | 274 |
| 2023-07-01 to 2023-09-30 | 23,231,217 | shares | 92 |
| 2023-01-01 to 2023-09-30 | 23,129,795 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | -0.25 | USD/shares | 92 |
| 2024-01-01 to 2024-09-30 | -1.11 | USD/shares | 274 |
| 2023-07-01 to 2023-09-30 | -1.97 | USD/shares | 92 |
| 2023-01-01 to 2023-09-30 | -3.28 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | -0.25 | USD/shares | 92 |
| 2024-01-01 to 2024-09-30 | -1.11 | USD/shares | 274 |
| 2023-07-01 to 2023-09-30 | -1.97 | USD/shares | 92 |
| 2023-01-01 to 2023-09-30 | -3.28 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | -101,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -258,000 | USD | 274 |
| 2023-07-01 to 2023-09-30 | 401,000 | USD | 92 |
| 2023-01-01 to 2023-09-30 | 638,000 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 46,598,000 | USD | |
| At 2023-12-31 | 50,316,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | 5,704,000 | USD | 274 |
| 2023-01-01 to 2023-09-30 | 8,484,000 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | -7,792,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -31,130,000 | USD | 274 |
| 2023-07-01 to 2023-09-30 | -46,721,000 | USD | 92 |
| 2023-01-01 to 2023-09-30 | -80,404,000 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 192,554,000 | USD | |
| At 2023-12-31 | 207,067,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 72,396,000 | USD | |
| At 2023-12-31 | 72,496,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 15,459,000 | USD | |
| At 2023-12-31 | 13,454,000 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 10,170,000 | USD | |
| At 2023-12-31 | 10,057,000 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 33,762,000 | USD | |
| At 2023-12-31 | 34,591,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 34,233,000 | USD | |
| At 2023-12-31 | 42,241,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 49,136,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 149,582,000 | USD | 274 |
| 2023-07-01 to 2023-09-30 | 80,485,000 | USD | 92 |
| 2023-01-01 to 2023-09-30 | 178,945,000 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 23,320,000 | USD | |
| At 2023-12-31 | 21,840,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 41,344,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 118,452,000 | USD | 274 |
| 2023-07-01 to 2023-09-30 | 33,764,000 | USD | 92 |
| 2023-01-01 to 2023-09-30 | 98,541,000 | USD | 273 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 47,490,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 137,172,000 | USD | 274 |
| 2023-07-01 to 2023-09-30 | 50,203,000 | USD | 92 |
| 2023-01-01 to 2023-09-30 | 141,223,000 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 3,518,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 15,712,000 | USD | 274 |
| 2023-07-01 to 2023-09-30 | 4,489,000 | USD | 92 |
| 2023-01-01 to 2023-09-30 | 14,126,000 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 23,817,704 | shares | |
| At 2023-12-31 | 23,324,750 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 1,719,000 | USD | |
| At 2023-12-31 | 1,225,000 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 19,017,000 | USD | |
| At 2023-12-31 | 20,338,000 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 20,147,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 91,213,000 | USD | |
| At 2023-12-31 | 98,161,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 44,615,000 | USD | |
| At 2023-12-31 | 47,845,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 4,071,000 | USD | |
| At 2023-12-31 | 3,825,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 9,783,000 | USD | |
| At 2023-12-31 | 13,846,000 | USD |
Net deferred tax liabilities
Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 8,384,000 | USD | |
| At 2023-12-31 | 8,539,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | -6,064,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -26,389,000 | USD | 274 |
| 2023-07-01 to 2023-09-30 | -45,318,000 | USD | 92 |
| 2023-01-01 to 2023-09-30 | -75,256,000 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | -4,106,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -25,637,000 | USD | 274 |
| 2023-07-01 to 2023-09-30 | -46,376,000 | USD | 92 |
| 2023-01-01 to 2023-09-30 | -76,234,000 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 19,257,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 54,956,000 | USD | 274 |
| 2023-07-01 to 2023-09-30 | 17,011,000 | USD | 92 |
| 2023-01-01 to 2023-09-30 | 50,487,000 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | 15,924,000 | USD | 274 |
| 2023-01-01 to 2023-09-30 | 13,008,000 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 687,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 964,000 | USD | 274 |
| 2023-07-01 to 2023-09-30 | -398,000 | USD | 92 |
| 2023-01-01 to 2023-09-30 | 176,000 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 1,728,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 4,741,000 | USD | 274 |
| 2023-07-01 to 2023-09-30 | 1,403,000 | USD | 92 |
| 2023-01-01 to 2023-09-30 | 5,148,000 | USD | 273 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | -244,000 | USD | 274 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | 348,000 | USD | 274 |
| 2023-01-01 to 2023-09-30 | -738,000 | USD | 273 |
Operating lease payments
Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | 3,494,000 | USD | 274 |
| 2023-01-01 to 2023-09-30 | 3,016,000 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | 1,154,000 | USD | 274 |
| 2023-01-01 to 2023-09-30 | -7,140,000 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | 2,048,000 | USD | 274 |
| 2023-01-01 to 2023-09-30 | -6,452,000 | USD | 273 |
Inspect the source
- Entity
- INOGEN, INC. / CIK 0001294133
- Captured
- 2026-09-20T07:50:14.833Z
- SEC response SHA-256
57d623a27c745f50e6ba92669a82245e80f90aa3643a67978611e0dd35fb3c72
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001294133.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))